Medicale Corp. (MCLE) Cash & Equivalents (2021 - 2024)

Medicale (MCLE) has 4 years of Cash & Equivalents data on file, last reported at $159.0 in Q4 2024.

• Quarterly Cash & Equivalents changed 0.0% year-over-year to $159.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $159.0 (changed 0.0% YoY) and the FY2024 annual result came in at $159.0, changed 0.0% from the prior year.
• Cash & Equivalents was little changed at $159.0 in Q4 2024, from $159.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $23900.0 in Q1 2021 to a low of $159.0 in Q4 2022.
• A 4-year average of $4878.6 and a median of $159.0 in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 98.56% — and 2023, when it changed 0.0%.
• Tracing MCLE's Cash & Equivalents over 4 years: stood at $3379.0 in 2021, then slumped by 95.29% to $159.0 in 2022, then changed by 0.0% to $159.0 in 2023, then changed by 0.0% to $159.0 in 2024.
• The last three Cash & Equivalents figures came in at $159.0 (Q4 2024), $159.0 (Q3 2024), and $159.0 (Q2 2024), per Business Quant data.